Top compounds associated with response to TMEM260


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC -0.43 0.2
mRNA Dasatinib FIMM pan-cancer AAC -0.22 0.2
mRNA AZD6244 UHNBreast pan-cancer AAC -0.18 0.5
mRNA Imatinib FIMM pan-cancer AAC -0.16 0.4
mRNA QW-BI-011 CTRPv2 pan-cancer AAC -0.16 0.02
mRNA embelin GDSC1000 pan-cancer AAC -0.14 7e-05
mRNA Bexarotene FIMM pan-cancer AAC -0.14 0.4
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.13 0.3
mRNA lapatinib UHNBreast pan-cancer AAC -0.13 0.7
mRNA AZD0530 FIMM pan-cancer AAC -0.13 0.4
Download CSV